Drug Type Monoclonal antibody |
Synonyms NBG 017, NBG017 |
Target |
Action modulators |
Mechanism GPCR modulators(G-protein coupled receptor modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hypoglycemia | Discovery | Japan | 29 Mar 2024 |






